NaviFUS Corp. (6872.TWO)
TWD 23.35
(-9.85%)
TWD 23.35
(-9.85%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -123.12 Million TWD | 44.89% |
| 2022 | -223.43 Million TWD | 26.83% |
| 2021 | -305.35 Million TWD | -153.92% |
| 2020 | -120.25 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -276.17 Million TWD | -124.3% |
| 2024 Q2 | -163.57 Million TWD | 40.77% |
| 2023 FY | -123.12 Million TWD | 44.89% |
| 2023 Q1 | -203.99 Million TWD | 8.7% |
| 2023 Q2 | -148.65 Million TWD | 27.13% |
| 2023 Q4 | -123.12 Million TWD | 0.0% |
| 2022 Q4 | -223.43 Million TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -59.816% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 53.39% |
| Level Biotechnology Inc. | -453.9 Million TWD | 72.873% |
| Sagittarius Life Science Corp | -120.57 Million TWD | -2.122% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 37.306% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 124.633% |
| GlycoNex Incorporation | -148.56 Million TWD | 17.122% |
| VBI | -25.31 Million TWD | -386.368% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 405.789% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 189.227% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 53.108% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 502.672% |
| Visgeneer Inc. | 31.28 Million TWD | 493.585% |
| Mycenax Biotech Inc. | 207 Million TWD | 159.48% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 81.909% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 8.285% |
| Neith Corporation | -150.31 Million TWD | 18.084% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 119.81% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -113.551% |
| Enimmune corporation | -314.15 Million TWD | 60.807% |
| TaiRx, Inc. | -147.86 Million TWD | 16.731% |
| CHO Pharma, Inc. | -203.79 Million TWD | 39.581% |
| EirGenix Inc. | -4.58 Billion TWD | 97.316% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -45.263% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 201.868% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 96.174% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 61.209% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -521.456% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 487.089% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 342.595% |
| RBC Bioscience Corporation | 422.18 Million TWD | 129.165% |
| BiOptic Inc. | 12.59 Million TWD | 1077.835% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 86.962% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -21.326% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 25.456% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 139.104% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -91.429% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 266.276% |
| Sinew Pharma Inc. | -160.34 Million TWD | 23.21% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 49.098% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 63.504% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 70.161% |
| AP Biosciences Inc | -196.52 Million TWD | 37.348% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 117.878% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -976.585% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 85.16% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 109.071% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 70.322% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 41.182% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | 14.412% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 62.749% |
| TCI GENE Inc. | -689.25 Million TWD | 82.136% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -3.524% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 90.595% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 701.128% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -20.869% |
| PharmaEngine, Inc. | -860.8 Million TWD | 85.696% |
| Savior Lifetec Corporation | -812.54 Million TWD | 84.846% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 58.953% |
| OBI Pharma, Inc. | -398.22 Million TWD | 69.08% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 66.305% |
| Acepodia, Inc. | -6.02 Billion TWD | 97.955% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 96.38% |